ClinicalTrialStartPulse: Phase 1, page 4 of 4
Records 351 to 500 of the 500 newest listed for this hub. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
| Record | Phase | Conditions | Enrollment |
|---|---|---|---|
| Surrozen Operating, Inc. | Phase 1 | Diabetic Macular Edema (DME) | 9 |
| Qilu Pharmaceutical (Hainan) Co., Ltd. | Phase 1 | Chemotherapy-Induced Nausea and Vomiting (CINV) | 42 |
| MycoMedica Life Sciences PBC | Phase 1 | Premenstrual Dysphoric Disorder ( PMDD); PMDD | 32 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 | Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO) | 60 |
| Memorial Sloan Kettering Cancer Center | Phase 1 | Transplant Failure or Rejection of Bone Marrow (Graft vs Host Disease, GVHD) | 16 |
| Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | Phase 1 | Poliomyelitis Vaccines | 60 |
| Guangzhou Panyu Central Hospital | Phase 1 | Healhty | 56 |
| Department of Hematology,Rheumatology and Immunology,Pu'er People's Hospital | Phase 1 | Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma; Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia | 42 |
| Memorial Sloan Kettering Cancer Center | Phase 1 | Breast Cancer; Invasive Breast Cancer | 10 |
| Rockefeller University | Phase 1 | Fanconi Anemia; Head and Neck Cancer; Squamous Cell Carcinoma; Squamous Cell Cancer of Head and Neck (SCCHN) | 80 |
| National Medical Research Radiological Centre of the Ministry of Health of Russia | Phase 1 | Pancreatic Cancer Non-resectable | 12 |
| Carilion Clinic | Phase 1 | Breast Reconstruction; Free Flap Reconstruction | 60 |
| AbbVie | Phase 1 | Hepatocellular Carcinoma (HCC) | 3 |
| Merck Sharp & Dohme LLC | Phase 1 | Advanced or Metastatic Solid Tumors | 30 |
| Genentech, Inc. | Phase 1 | Non-cystic Fibrosis Bronchiectasis; Chronic Obstructive Pulmonary Disease | 17 |
| Soterix Medical | Phase 1 | Treatment Resistant Depression (TRD) | |
| ViiV Healthcare | Phase 1 | HIV Infections | 30 |
| University of Maryland, Baltimore | Phase 1 | Prematurity Complications | 150 |
| Yale University | Phase 1 | Opioid Use Disorder; OAT | 110 |
| Bristol-Myers Squibb | Phase 1 | Acute Myeloid Leukemia; Myelodysplastic Syndrome | 34 |
| Sunshine Lake Pharma Co., Ltd. | Phase 1 | Esophageal Cancer; Advanced Solid Tumor | |
| GE Healthcare | Phase 1 | Malignant Solid Tumor; Oncology | 19 |
| SystImmune Inc. | Phase 1 | Relapsed/Refractory Acute Myeloid Leukemia | 52 |
| Michigan State University | Phase 1 | Healthy | 300 |
| Eli Lilly and Company | Phase 1 | Overweight or Obesity; Healthy | 77 |
| GRIN Therapeutics, Inc. | Phase 1 | Healthy Adult Participants | 36 |
| Ethyreal Bio, Inc. | Phase 1 | Thyroid Eye Disease (TED); Graves' Disease; Eye Diseases, Hereditary; Eye Diseases; Exophthalmos; Orbital Diseases | 72 |
| Antido Therapeutics (Australia) Pty Ltd | Phase 1 | Advanced Solid Tumor | 26 |
| University of Calgary | Phase 1 | Irritable Bowel Syndrome (IBS); Microbiome | 180 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 1 | Hypertension | 40 |
| XingImaging, LLC | Phase 1 | Parkinsons Disease (PD); Healthy Elderly Volunteers | 18 |
| Epygenix | Phase 1 | Healthy Participants | 88 |
| Massachusetts General Hospital | Phase 1 | Bacterial Vaginosis | 280 |
| OcuCell | Phase 1 | Corneal Endothelial Cell Dysfunction; Corneal Endothelial Cell | 30 |
| Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd | Phase 1 | Advanced Solid Tumors | 110 |
| Hadassah Medical Organization | Phase 1 | Relapsed/Refractory Multiple Myeloma (RRMM); Light-Chain Amyloidosis | 160 |
| ModernaTX, Inc. | Phase 1 | Seasonal Influenza | 96 |
| Humanis Saglık Anonim Sirketi | Phase 1 | Type 2 Diabetes Mellitus (T2DM); Cardiovascular Diseases | 36 |
| Suzhou Ribo Life Science Co. Ltd. | Phase 1 | Healthy | 24 |
| M.D. Anderson Cancer Center | Phase 1 | Metastatic Colorectal Adenocarcinoma; Metastatic Pancreatic Ductal Adenocarcinoma; Stage IV Colorectal Cancer AJCC v7; Stage IV Pancreatic Cancer AJCC v6 and v7; Stage IVA Colorectal Cancer AJCC v7; Stage IVB Colorectal Cancer AJCC v7 | 119 |
| Novo Nordisk A/S | Phase 1 | Overweight; Obesity; Type 2 Diabetes | 60 |
| Haya Therapeutics, Inc. | Phase 1 | Nonobstructive Hypertrophic Cardiomyopathy | 10 |
| Alpheus Medical, Inc. | Phase 1 | Glioblastom WHO Grade 4; GBM; bGBM; Butterfly GBM; Bihemispheric GBM; Glioblastoma | 30 |
| VA Office of Research and Development | Phase 1 | Homelessness | 192 |
| Harmony Biosciences Management, Inc. | Phase 1 | Healthy Participants | 12 |
| AbbVie | Phase 1 | Healthy Subjects | 60 |
| Naval Health Research Center | Phase 1 | Alcohol Misuse; Sexual Assault | 120 |
| Novo Nordisk A/S | Phase 1 | Overweight; Obesity; Type 2 Diabetes | 60 |
| Sanofi | Phase 1 | Healthy Volunteer | 14 |
| Sanofi | Phase 1 | Renal Impairment; Healthy Volunteers | 16 |
| Corium Innovations, Inc. | Phase 1 | Healthy Female Participants; Postmenopause | 68 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | HIV-1 | 105 |
| Otsuka Pharmaceutical Factory, Inc. | Phase 1 | Healthy Volunteers | 24 |
| Harmony Biosciences Management, Inc. | Phase 1 | Sleep Deprivation | 12 |
| Viking Therapeutics, Inc. | Phase 1 | Obese Adults | 56 |
| AbbVie | Phase 1 | Healthy Volunteers | 60 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 1 | Hepatic Impairment (Moderate or Mild) & Normal Hepatic Function | 32 |
| Tangram Therapeutics Plc | Phase 1 | Healthy Participants | 40 |
| Beijing Gene Key Life Technology Co., Ltd | Phase 1 | Hepatocellular Carcinoma (HCC); Unresectable Hepatocellular Carcinoma | 13 |
| Ascletis Pharma (China) Co., Limited | Phase 1 | Chronic Weight Management | 84 |
| Shanghai JMT-Bio Inc. | Phase 1 | Valid MeSH Conditiongs | 90 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Healthy | 17 |
| Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 1 | Healthy | 8 |
| Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 | Hypertension | 30 |
| Tridem Bioscience FlexCo | Phase 1 | Parkinson Disease (PD); Idiopathic Parkinson's Disease | 36 |
| City Therapeutics | Phase 1 | Stargardt Disease 1; STGD1; Healthy Volunteers | 48 |
| Jiangsu Aidea Pharmaceutical Group Co., Ltd. | Phase 1 | Healthy Adult Participants | 47 |
| National Taiwan University Hospital | Phase 1 | Critical Care Medicine; Emergency Medical Services; Cardiac Arrest (CA); Seizure | 100 |
| Celgene | Phase 1 | Healthy Volunteers | 24 |
| Madrigal Pharmaceuticals, Inc. | Phase 1 | MASH - Metabolic Dysfunction-Associated Steatohepatitis; Heart Failure With Preserved Ejection Fraction (HFPEF) | 90 |
| Hangzhou Huasai Biomedicine Co., Ltd. | Phase 1 | Advanced NSCLC | 24 |
| Canadian Myeloma Research Group | Phase 1 | Relapsed Refractory Multiple Myeloma (RRMM) | 108 |
| Shandong New Time Pharmaceutical Co., LTD | Phase 1 | Systemic Lupus Erythematosus (SLE) | 64 |
| Corvus Pharmaceuticals, Inc. | Phase 1 | Hidradenitis Suppurativa (HS) | 25 |
| M.D. Anderson Cancer Center | Phase 1 | Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer | 409 |
| Alzheon Inc. | Phase 1 | Healthy Participants Study | 84 |
| Epygenix | Phase 1 | Drug Drug Interaction | 54 |
| Corregene Biotechnology Co., Ltd | Phase 1 | Advanced Solid Tumors | 6 |
| ORGANOIDSCIENCES LTD. | Phase 1 | Crohn's Diseases; Crohn's Disease | 18 |
| Kymera Therapeutics, Inc. | Phase 1 | Healthy Participants | 54 |
| BeOne Medicines | Phase 1 | Healthy Adult Participants | 24 |
| Eli Lilly and Company | Phase 1 | Healthy Volunteers | 15 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Tuberculosis | 116 |
| InThera Inc. Korea | Phase 1 | Norovirus Infections; Norovirus Gastroenteritis | 30 |
| The Netherlands Cancer Institute | Phase 1 | Lung Cancer (NSCLC); HER2 Expression; HER2 Gene Mutation | 20 |
| National Cancer Institute (NCI) | Phase 1 | Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Invasive Breast Carcinoma; Locally Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Metastatic HER2-Low Breast Carcinoma | 36 |
| City of Hope Medical Center | Phase 1 | Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma | 10 |
| Northwestern University | Phase 1 | Inguinal Hernia Unilateral; Inguinal Hernia Bilateral; Inguinal Hernia Without Obstruction or Gangrene; Inguinal Hernia, Without Mention of Obstruction or Gangrene | 30 |
| Medical University of South Carolina | Phase 1 | Breast Cancer | 84 |
| University of Kansas Medical Center | Phase 1 | Hematopoietic Stem Cell Transplant | 30 |
| Vanderbilt-Ingram Cancer Center | Phase 1 | Refractory Clear Cell Renal Cell Carcinoma; Metastatic Clear Cell Renal Cell Carcinoma | 12 |
| Providence Health & Services | Phase 1 | Ductal Carcinoma in Situ; Lobular Carcinoma in Situ | 24 |
| Johns Hopkins University | Phase 1 | Cannabis Intoxication | 70 |
| Misr University for Science and Technology | Phase 1 | Oral Ulcer; Oral Mucositis; Aphthous Stomatitis | 10 |
| City of Hope Medical Center | Phase 1 | Recurrent Glioblastoma; Recurrent Malignant Glioma; Recurrent WHO Grade II Glioma; Recurrent WHO Grade III Glioma | 19 |
| Biotech Pharmaceutical Co., Ltd. | Phase 1 | Asthma | 20 |
| Yale University | Phase 1 | Epilepsy; Seizures | 5 |
| City of Hope Medical Center | Phase 1 | Chronic Graft Versus Host Disease; Steroid Refractory Graft Versus Host Disease | 18 |
| George Washington University | Phase 1 | Distal Radius Fracture | 62 |
| Johns Hopkins University | Phase 1 | Psilocybin Intoxication | 80 |
| Heidelberg University | Phase 1 | Recurrent IDH1R132H-mutant Astrocytoma, Grade 2 - 4 | 45 |
| Columbia University | Phase 1 | Insulin Resistance; Hyperinsulinemia; Obesity; Healthy | 20 |
| University of Florida | Phase 1 | Pancreatic Ductal Adenocarcinoma | 36 |
| The Cleveland Clinic | Phase 1 | Alcohol-associated Liver Disease | 30 |
| Peking University First Hospital | Phase 1 | Limb Girdle Muscular Dystrophy Type 2D/R3 | 8 |
| City of Hope Medical Center | Phase 1 | Hematopoietic and Lymphoid Cell Neoplasm | 36 |
| University of Michigan Rogel Cancer Center | Phase 1 | Breast Cancer | 32 |
| Memorial Sloan Kettering Cancer Center | Phase 1 | Acute Myeloid Leukemia (AML) | 8 |
| Masonic Cancer Center, University of Minnesota | Phase 1 | Smoking, Cigarette | 47 |
| Jinling Hospital, China | Phase 1 | Sperm DNA Fragmentation | 114 |
| City of Hope Medical Center | Phase 1 | Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia | 17 |
| Memorial Sloan Kettering Cancer Center | Phase 1 | Multiple Myeloma; Amyloidosis | 46 |
| University of Chicago | Phase 1 | Lymphoma, B-Cell; Multiple Myeloma | 32 |
| Johns Hopkins University | Phase 1 | Cannabis Intoxication | 70 |
| Washington University School of Medicine | Phase 1 | B Cell Lymphoma; Aggressive Lymphoma; Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Transformed Lymphoma; Follicular Lymphoma Grade 3 | 9 |
| Instituto Nacional de Cancer, Brazil | Phase 1 | Head and Neck Neoplasms; Mucositis Oral; Radiotherapy; Complications | 20 |
| UNC Lineberger Comprehensive Cancer Center | Phase 1 | B-Cell ALL; ALL (Acute B-Lymphoblastic Leukemia); Philadelphia Chromosome-Negative Lymphoblastic Leukemia; CD19-positive B-cell Acute | 13 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | West Nile Viral Infection | 30 |
| Bożenna Dembowska Bagińska | Phase 1 | Medulloblastoma Recurrent; Medulloblastoma | 48 |
| City of Hope Medical Center | Phase 1 | B Acute Lymphoblastic Leukemia | 18 |
| Murdoch Childrens Research Institute | Phase 1 | Streptococcal Pharyngitis | 60 |
| M.D. Anderson Cancer Center | Phase 1 | Advanced Solid Malignancies | 7 |
| M.D. Anderson Cancer Center | Phase 1 | Tumor; Metastatic Melanoma; Melanoma | 21 |
| M.D. Anderson Cancer Center | Phase 1 | Metastatic Epidural Spinal Cord Compression | 43 |
| Massachusetts General Hospital | Phase 1 | Smoldering Multiple Myeloma | 19 |
| Memorial Sloan Kettering Cancer Center | Phase 1 | Multiple Myeloma | 20 |
| Fred Hutchinson Cancer Center | Phase 1 | Prostate Cancer | 18 |
| M.D. Anderson Cancer Center | Phase 1 | Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 | 27 |
| Memorial Sloan Kettering Cancer Center | Phase 1 | Acute Lymphocytic Leukemia; Lymphoma | 19 |
| M.D. Anderson Cancer Center | Phase 1 | Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia | 32 |
| University of California, Irvine | Phase 1 | Advanced Lung Non-Small Cell Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Refractory Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8 | 6 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 | High Risk Cancer; Pancreatic Cancer | 31 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 1 | Advanced Solid Tumor | 27 |
| City of Hope Medical Center | Phase 1 | Acute Myeloid Leukemia | 56 |
| Memorial Sloan Kettering Cancer Center | Phase 1 | Solid Malignancy; Lymphoma | 67 |
| Vinmec Research Institute of Stem Cell and Gene Technology | Phase 1 | Frailty Syndrome; Aging | 20 |
| Stony Brook University | Phase 1 | Heart Failure With Reduced Ejection Fraction; Cognitive Impairment, Mild; Neuroinflammation; Vascular Contributions to Cognitive Impairment and Dementia (VCID) | 18 |
| Baylor College of Medicine | Phase 1 | Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type; Classical Hodgkin Lymphoma | 27 |
| Baylor College of Medicine | Phase 1 | Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome; Acute Myeloid Leukemia; Chronic Myelogenous Leukemia; Non Hodgkin Lymphoma; Hemophagocytic Lymphohistiocytosis | 15 |
| Tata Memorial Hospital | Phase 1 | Breast Cancer; Oral Cancer | 12 |
| The Cooper Health System | Phase 1 | Chronic Subdural Hematoma | 10 |
| Georgetown University | Phase 1 | Nonsmall Cell Lung Cancer Stage | 35 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 1 | Bladder Cancer | 20 |
| The Affiliated Hospital of Qingdao University | Phase 1 | Healthy Participants | 124 |
| Baylor College of Medicine | Phase 1 | Neural Tube Defects | 38 |
| Wayne State University | Phase 1 | Spinal Cord Injuries; Aging | 24 |
| Suzhou UgeneX Therapeutics Co., Ltd. | Phase 1 | Retinitis Pigmentosa (RP) | 12 |
| Memorial Sloan Kettering Cancer Center | Phase 1 | Solid Tumors | 18 |
| M.D. Anderson Cancer Center | Phase 1 | Tumor; Adenocarcinoma | 15 |
| The Third Xiangya Hospital of Central South University | Phase 1 | Healthy Participants | 66 |
All ClinicalTrialStartPulse record reports